{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T22:00:25Z","timestamp":1764194425900},"reference-count":20,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2019.17669","type":"journal-article","created":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T16:31:10Z","timestamp":1576686670000},"page":"e1917669","source":"Crossref","is-referenced-by-count":12,"title":["Antiretroviral Prescribing Practices Among Pregnant Women Living With HIV in the United States, 2008-2017"],"prefix":"10.1001","volume":"2","author":[{"given":"Kathleen M.","family":"Powis","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Massachusetts General Hospital, Boston"},{"name":"Department of Pediatrics, Massachusetts General Hospital, Boston"},{"name":"Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanling","family":"Huo","sequence":"additional","affiliation":[{"name":"Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paige L.","family":"Williams","sequence":"additional","affiliation":[{"name":"Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"},{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"},{"name":"Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Kacanek","sequence":"additional","affiliation":[{"name":"Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Jao","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois"},{"name":"Division of Infectious Diseases, Department of Pediatrics, Ann & Robert H. Lurie Children\u2019s Hospital of Chicago, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunjal","family":"Patel","sequence":"additional","affiliation":[{"name":"Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"},{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"George R.","family":"Seage","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell B.","family":"Van Dyke","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Tulane University School of Medicine, New Orleans, Louisiana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen G.","family":"Chadwick","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois"},{"name":"Division of Infectious Diseases, Department of Pediatrics, Ann & Robert H. Lurie Children\u2019s Hospital of Chicago, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the Pediatric HIV\/AIDS Cohort Study (PHACS)","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[2019,12,18]]},"reference":[{"issue":"RR-11","key":"zoi190670r1","first-page":"1","article-title":"Recommendations of the US Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus.","volume":"43","author":"Centers for Disease Control and Prevention","year":"1994","journal-title":"MMWR Recomm Rep"},{"issue":"18","key":"zoi190670r2","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1056\/NEJM199411033311801","article-title":"Reduction of maternal\u2013infant transmission of human immunodeficiency virus type 1 with zidovudine treatment: Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.","volume":"331","author":"Connor","year":"1994","journal-title":"N Engl J Med"},{"issue":"RR-2","key":"zoi190670r3","first-page":"1","article-title":"Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States.","volume":"47","author":"Centers for Disease Control and Prevention","year":"1998","journal-title":"MMWR Recomm Rep"},{"issue":"7","key":"zoi190670r6","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1089\/apc.2011.0068","article-title":"In utero and postnatal exposure to antiretrovirals among HIV-exposed but uninfected children in the United States.","volume":"25","author":"Griner","year":"2011","journal-title":"AIDS Patient Care STDS"},{"issue":"2","key":"zoi190670r7","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1089\/apc.2013.0165","article-title":"Trends in antiretroviral drug use during pregnancy among HIV-infected women on Medicaid: 2000-2007.","volume":"28","author":"Phiri","year":"2014","journal-title":"AIDS Patient Care STDS"},{"key":"zoi190670r8","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3389\/fimmu.2016.00199","article-title":"The PHACS SMARTT Study: assessment of the safety of in utero exposure to antiretroviral drugs.","volume":"7","author":"Van Dyke","year":"2016","journal-title":"Front Immunol"},{"issue":"1","key":"zoi190670r9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/QAD.0000000000000916","article-title":"Antiretroviral exposure during pregnancy and adverse outcomes in HIV-exposed uninfected infants and children using a trigger-based design.","volume":"30","author":"Williams","year":"2016","journal-title":"AIDS"},{"issue":"8","key":"zoi190670r13","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1097\/QAD.0b013e3283388742","article-title":"Prevalence of transmitted drug resistance associated mutations and HIV-1 subtypes in new HIV-1 diagnoses, U.S.\u20142006.","volume":"24","author":"Wheeler","year":"2010","journal-title":"AIDS"},{"issue":"12","key":"zoi190670r14","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1086\/jid.2004.189.issue-12","article-title":"The epidemiology of antiretroviral drug resistance among drug-naive HIV-1\u2013infected persons in 10 US cities.","volume":"189","author":"Weinstock","year":"2004","journal-title":"J Infect Dis"},{"issue":"1","key":"zoi190670r15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1310\/hct0801-1","article-title":"Prevalence of antiretroviral drug resistance and resistance-associated mutations in antiretroviral therapy-na\u00efve HIV-infected individuals from 40 United States cities.","volume":"8","author":"Ross","year":"2007","journal-title":"HIV Clin Trials"},{"key":"zoi190670r16","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4897501","article-title":"Antiretroviral resistance and pregnancy characteristics of women with perinatal and nonperinatal HIV infection.","volume":"2016","author":"Lazenby","year":"2016","journal-title":"Infect Dis Obstet Gynecol"},{"issue":"6","key":"zoi190670r19","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1310\/hct1106-303","article-title":"Treatment change in pregnancy is a significant risk factor for detectable HIV-1 RNA in plasma at end of pregnancy.","volume":"11","author":"Floridia","year":"2010","journal-title":"HIV Clin Trials"},{"issue":"5","key":"zoi190670r20","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1097\/QAI.0000000000001954","article-title":"Does changing antiretroviral therapy in the first trimester of pregnancy for safety concerns have an impact on viral suppression?","volume":"80","author":"Peyronnet","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"key":"zoi190670r4","unstructured":"Public Health Service Task Force. Recommendations for use of antiretroviral drugs in pregnant HIV-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. https:\/\/aidsinfo.nih.gov\/contentfiles\/PerinatalGL001020.pdf. Published July 8, 2008. Accessed December 2, 2018."},{"key":"zoi190670r5","unstructured":"Centers for Disease Control and Prevention. Recommendations for use of antiretroviral drugs in pregnant HIV-1\u2013infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. https:\/\/npin.cdc.gov\/publication\/recommendations-use-antiretroviral-drugs-pregnant-hiv-1-infected-women-maternal-health. Accessed February 6, 2019."},{"key":"zoi190670r10","unstructured":"US Department of Health and Human Services. Archived perinatal guidelines. https:\/\/aidsinfo.nih.gov\/guidelines\/archive\/perinatal-guidelines. Accessed December 12, 2018."},{"key":"zoi190670r11","unstructured":"Perinatal HIV Guidelines Working Group. Recommendations for use of antiretroviral drugs in pregnant HIV-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. 2007. https:\/\/aidsinfo.nih.gov\/ContentFiles\/PerinatalGL02112007901.pdf. Accessed November 30, 2016."},{"key":"zoi190670r12","unstructured":"Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for use of antiretroviral drugs in pregnant HIV-1\u2013infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. https:\/\/aidsinfo.nih.gov\/contentfiles\/PerinatalGL003482.pdf. Accessed February 6, 2019."},{"key":"zoi190670r17","unstructured":"Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for use of antiretroviral drugs in pregnant HIV-1\u2013infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. 2016. https:\/\/aidsinfo.nih.gov\/contentfiles\/PerinatalGL003422.pdf. Accessed November 5, 2016."},{"key":"zoi190670r18","unstructured":"Antiretroviral Pregnancy Registry Steering Committee. The antiretroviral pregnancy registry interim report: 1 January 1989 through 31 January 2019. http:\/\/www.apregistry.com\/forms\/interim_report.pdf. Published June 2019. Accessed February 6, 2019."}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2757628\/powis_2019_oi_190670.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,13]],"date-time":"2021-02-13T03:04:32Z","timestamp":1613185472000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2757628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,18]]},"references-count":20,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.17669","relation":{},"ISSN":["2574-3805"],"issn-type":[{"type":"electronic","value":"2574-3805"}],"subject":[],"published":{"date-parts":[[2019,12,18]]}}}